Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Cipralex on HPA-axis activity, insulin sensitivity, and quality of life in women with PCOS
2010-022319-20Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in polycystic ovary syndrome (PCOS) comparing Cipralex with Placebo (2 arms). Primary endpoints: HPA-axis activity and Insulin sensitivity. Started Oct 2011; status: completed.
02
Drugs
escitalopram
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2010-022319-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022319-20.